Physician profile
Stephen G Bennett
NPI 1336183029
$37,563.14
in general payments reported to CMS, 2019-2025
51 companies · $2,648 in 2025
The $2,648 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,670 · 2020: $5,500 · 2021: $6,620 · 2022: $13K · 2023: $3,591 · 2024: $4,559 · 2025: $2,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,834 · Travel and Lodging: $1,669 · Honoraria: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,833.71 |
| Travel and Lodging | $1,669.34 |
| Honoraria | $295.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $11,661.11 | 2020-2025 | Jelmyto |
| Axonics, INC. | $10,159.35 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $3,385.64 | 2019-2025 | Ams 700, Axonics, Spaceoar Vue System - 10ml |
| Angiodynamics, INC. | $2,230.34 | 2024-2025 | Nanoknife |
| Astellas Pharma US INC | $1,390.32 | 2019-2025 | Xtandi, Myrbetriq |
| Medtronic USA, INC. | $999.54 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $927.40 | 2019-2025 | Provenge |
| Antares Pharma, INC. | $720.13 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $631.55 | 2019-2025 | Erleada, Akeega, Balversa |
| Teleflex LLC | $611.58 | 2021-2025 | Barrigel, Urolift |
| Abbvie INC. | $514.64 | 2019-2025 | Lupron Depot, Botox |
| Bayer Healthcare Pharmaceuticals INC. | $399.37 | 2023-2025 | |
| Pfizer INC. | $371.01 | 2019-2025 | |
| Inari Medical, INC. | $258.24 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Myriad Genetic Laboratories, INC. | $255.64 | 2021-2025 | Prolaris |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.